UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2023
Commission File Number: 001-39633
Abcam plc
(Translation of registrant’s name into English)
Discovery Drive
Cambridge Biomedical Campus
Cambridge, CB2 0AX
United Kingdom
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On October 12, 2023, Abcam plc (the “Company”) issued a press release (the “Announcement”) announcing the publication of an investor presentation (the “Investor Presentation”) and the publication and mailing of a letter from the Independent Directors of the Company urging shareholders to vote in support of the Company’s agreement to be acquired for $24.00 per share by Danaher Corporation. A copy of the Announcement and Investor Presentation are furnished herewith as Exhibits 99.1, and 99.2, respectively, to this Report of Foreign Private Issuer on Form 6-K.
EXHIBIT INDEX
Exhibit No. | Description | |
99.1 | Announcement dated October 12, 2023 | |
99.2 | Investor Presentation dated October 12, 2023 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ABCAM PLC | ||||||
Date: October 12, 2023 | By: | /s/ Alan Hirzel | ||||
Name: | Alan Hirzel | |||||
Title: | Chief Executive Officer |